Сравнение

Enfuvirtid vs. Plecanatid

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

159519-65-0

467426-54-6

Молекулярная масса

4491.88 g/mol

1682 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Enfuvirtid

Enfuvirtide binds the first heptad-repeat region (HR1) of the gp41 subunit of the HIV envelope protein. This prevents the conformational change required for fusion of the viral and cell membranes — the virus cannot enter the cell.

Plecanatid

Plecanatide is structurally analogous to the body's own uroguanylin and, like it, activates the GC-C receptor at the gut surface, raising cGMP and fluid secretion. Its pH-dependent activity shifts the effect toward the proximal small intestine.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Enfuvirtid	Plecanatid
Германия	Рецептурный	Не одобрено
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Enfuvirtid and Plecanatid?: Enfuvirtid is classified as "Исследования (прочее)", while Plecanatid is classified as "Исследования (прочее)". Enfuvirtid: Enfuvirtide is a synthetic 36-amino-acid peptide and the first HIV-1 fusion inhibitor. It binds the HR1 region of the viral envelope protein gp41, blocking viral entry into the cell. Approved for treatment-experienced HIV patients. Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Enfuvirtid or Plecanatid?: The highest available evidence level is "РКИ на людях" for Enfuvirtid and "РКИ на людях" for Plecanatid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Enfuvirtid and Plecanatid in Germany and the United States?: Германия: Enfuvirtid — Рецептурный, Plecanatid — Не одобрено. США: Enfuvirtid — Рецептурный, Plecanatid — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Enfuvirtid

Plecanatid

Германия

Рецептурный

Не одобрено

США

Рецептурный

Frequently asked questions

What is the difference between Enfuvirtid and Plecanatid?

Enfuvirtid is classified as "Исследования (прочее)", while Plecanatid is classified as "Исследования (прочее)". Enfuvirtid: Enfuvirtide is a synthetic 36-amino-acid peptide and the first HIV-1 fusion inhibitor. It binds the HR1 region of the viral envelope protein gp41, blocking viral entry into the cell. Approved for treatment-experienced HIV patients. Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Enfuvirtid or Plecanatid?

The highest available evidence level is "РКИ на людях" for Enfuvirtid and "РКИ на людях" for Plecanatid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Enfuvirtid and Plecanatid in Germany and the United States?

Германия: Enfuvirtid — Рецептурный, Plecanatid — Не одобрено. США: Enfuvirtid — Рецептурный, Plecanatid — Рецептурный. These are factual summaries with source and review date on the individual pages.